angiogenesis bpc 157 Comment “Curious” for the peptides newsletter Following the GLP-1 wave, few compounds are generating as much buzz as BPC-157 (Body Protection Compound- 157). In preclinical research, this peptide has shown intriguing effects on TB 500 vs BPC 157:

Today peptides, tomorrow homeopathy (...though at least for the latter, a presumption of safety would have a more rational basis) Instead of focusing on banning things a small subset of people are using and seeing benefit in, can we focus on modernizing the clinical trial system to promote efficient drug development

Whether combating leaky gut, IBS, or ulcers, BPC-157 shields and restores the delicate mucosal barrier, supporting systemic healing

Topical cream protocols Topical formulations allow targeted delivery to skin wounds, burns, and localized inflammation

The limitation: less regulatory oversight compared to branded pharmaceuticals